Dr. Jeffrey A. Holman, MD

Dr. Holman practices at Presbyterian Española Hospital in Espanola, New Mexico, part of Presbyterian Healthcare Services.

Dr. Holman's NPI, 1154309615, was assigned on January 5, 2006. Dr. Holman graduated from University of Texas Southwestern Medical School at Dallas in 1987. Dr. Holman holds South Carolina license 19118.

Dr. Holman's primary practice is Presbyterian Española Hospital, at 1010 Spruce Street, Espanola, NM 87532 in Rio Arriba County. The practice phone is (505) 753-1502.

Dr. Holman's primary practice is Presbyterian Española Hospital in Espanola, New Mexico, part of Presbyterian Healthcare Services. Dr. Holman is also affiliated with Presbyterian Hospital. The medical group on file is Presbyterian Medical Group. Dmand AI also links Dr. Holman to 3 more hospitals and 1 home health agency, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Holman practices, 6 sites in all. Vendor and product names are available with a free account.

Orthopaedic surgery is Dr. Holman's primary specialty in the NPI Registry, under taxonomy code 207X00000X. Dr. Holman is board certified in orthopaedic surgery by the American Board of Orthopaedic Surgery. Dr. Holman is licensed in South Carolina.

CMS data shows 360 Medicare services from Dr. Holman across 6 procedure codes in 2024, for 200 Medicare patients. Medicare paid $29,908 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 200 Medicare patients who saw Dr. Holman in 2024. The largest group is 65 to 74, with 89 patients. 75% of them have arthritis, and 71% have high blood pressure. 17% are also on Medicaid. Their average risk score is 1.10, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Holman's median patient age at 64, with 55% women.

In 2024, Dr. Holman wrote 310 Medicare Part D claims for 113 patients. 99% of them were for generic drugs. CMS names the drug for 242 of them, across 6 drugs with 11 or more claims each, at $5,957 in total drug cost. In 2023, CMS named 157 claims across 7 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Holman for performance year 2024, reported as part of a group. Dr. Holman accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 12 procedures of knee replacement by Dr. Holman, more than 39% of the clinicians it reports for that procedure.

Hip replacement: 1 to 10 procedures (CMS shows small counts as a range)

Lower limb (leg) arthroscopy (minimally invasive joint repair): 1 to 10 procedures (CMS shows small counts as a range)

CMS Open Payments shows 39 general payments to Dr. Holman from 8 drug and device companies from 2016 to 2025. Travel and lodging make up the largest share, 55% of the total. Zimmer Biomet Holdings, Inc. paid the most, $1,310.

Dr. Holman graduated from University of Texas Southwestern Medical School at Dallas in 1987.